The Aortic Endograft Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Aortic Endograft Market:
https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report
According to The Business Research Company’s Aortic Endograft Global Market Report 2024, The aortic endograft market size is expected to see strong growth in the next few years. It will grow to $4.08 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing prevalence of abdominal aortic aneurysmsm, growing preference for minimally invasive endovascular procedures, rising geriatric population, advancements in stent-graft materials and configurations, introduction of new stent-graft products. Major trends in the forecast period include adoption of endovascular abdominal aortic aneurysm (AAA) repair devices, effectiveness of unibody and non-unibody aortic stent, product innovation.
The growing prevalence of aortic aneurysms is expected to propel the growth of the aortic endograft market going forward. An aortic aneurysm is a localized and abnormal dilation or bulging of the aorta, which is the largest artery in the human body. Aortic endografts are used to treat aortic aneurysms because they are less invasive than traditional open surgery. A fabric-covered metal or polymer device is inserted through a catheter, strengthening weak aortic walls and lowering the risk of rupture. For instance, in February 2023, according to Government Digital Service, a UK-based public sector information website, around 274,800 men were offered screening, with 79.0% receiving a conclusive screen and 1,794 aneurysms being found April 2021 to March 2022. Therefore, the growing prevalence of aortic aneurysms is driving the growth of the aortic aneurysm market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13784&type=smp
The aortic endograft market covered in this report is segmented –
1) By Product: Abdominal Aortic Grafts, Thoracic Aortic Grafts
2) By Material: Metallic Endografts, Polymeric Endografts
3) By Procedure: Open Surgical Repair, Endovascular Aneurysm Repair (EVAR)
4) By End User: Hospitals, Ambulatory Surgical Centers
Major companies operating in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to gain a competitive edge in the market. The castor-branched aortic stent graft system is a medical device used for minimally invasive repair of the aorta and aortic arch, particularly in cases of Stanford type B aortic dissection (TBAD). For instance, in December 2021, Shanghai MicroPort Endovascular MedTech Group Co. Ltd., a China-based manufacturer of aortic and peripheral vascular intervention devices, launched the CastorTM Branched Aortic Stent-Graft System (CastorTM). The world’s first stent-graft device for simultaneous aortic and aortic arch repair with minimally invasive therapy. The distinctive unibody design of this device may conform to diverse arch anatomies and provide one-time access and release. This feature guarantees the safe and easy reconstruction of the left subclavian artery while also mitigating the risk of endoleaks and promoting long-term stability.
The aortic endograft market report table of contents includes:
1. Executive Summary
2.Aortic Endograft Market Characteristics
3.Aortic Endograft Market Trends And Strategies
4.Aortic Endograft Market analysis
5.Aortic Endograft Market Size And Growth
6.Aortic Endograft Segmentation
7.Aortic Endograft Regional And Country Analysis
.
.
.
27.Aortic Endograft Competitive Landscape And Company Profiles
28.Aortic Endograft Key Mergers And Acquisitions
29.Aortic Endograft Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Cardinal Health Inc.
- Abbott Laboratories
- Medtronic Plc
- Becton
- Dickinson and Company
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
